Canopy Growth Corporation (CGC) États Financiers et Données Historiques

Canopy Growth Corporation (CGC) — Prix $0.92 HealthcareDrug Manufacturers - Specialty & Generic — NASDAQ

Derniers résultats publiés:

États financiers détaillés de Canopy Growth Corporation (CGC): compte de résultat, bilan et tableau de flux de trésorerie. Suivez l'évolution des marges, de la dette, de la liquidité et de la rentabilité d'une année sur l'autre avec jusqu'à 20 ans d'historique.

Résumé de l'Analyse

Canopy Growth Corporation a enregistré un chiffre d'affaires de $284.6M sur le dernier exercice, avec un CAGR sur 5 ans de -12.2%.

Marges des 12 derniers mois: marge brute 22.9%, marge opérationnelle -46.9%, marge nette -73.9%.

Au prix actuel de $0.92, CGC affiche des résultats négatifs (PER non significatif) et un ROE de -29.85%. La capitalisation boursière s'établit à $387M.

Compte de Résultat (10 ans)

Année2017201820192020202120222023202420252026
Revenus$39.9M$77.9M$226.3M$398.8M$546.6M$475.7M$333.3M$297.1M$269.0M$284.6M
Coût des Ventes$2.3M$3.8M$137.4M$430.5M$479.7M$663.1M$396.8M$216.3M$189.5M$214.9M
Marge Brute$38.7M$74.2M$88.9M-$31.7M$67.0M-$187.4M-$63.5M$80.9M$79.5M$69.7M
R&D$810000$1.5M$15.2M$61.8M$57.6M$32.3M$21.7M$4.6M00
Frais Généraux$38.6M$131.1M$605.8M$867.7M$523.8M$361.1M$298.0M$180.6M$121.7M$122.9M
Charges Opérationnelles$52.8M$153.1M$642.6M$1.64B$1.31B$831.4M$2.57B$309.6M$196.7M$142.8M
Résultat Opérationnel-$14.1M-$107.8M-$615.2M-$1.67B-$1.24B-$1.02B-$2.63B-$228.7M-$117.1M-$73.1M
EBITDA-$650000-$95.7M-$567.1M-$1.38B-$449.7M-$53.0M-$2.88B-$312.8M-$479.3M-$188.2M
Charges d'Intérêt$66000$784000$18.4M$6.7M$8.5M$103.9M$126.2M$105.4M$74.6M$38.2M
Résultat Avant Impôts-$10.3M-$51.5M-$709.2M-$1.51B-$1.68B-$267.9M-$3.09B-$471.4M-$597.0M-$262.9M
Impôts$2.7M-$392000$4.1M-$121.6M-$13.1M-$8.9M-$5.7M$12.3M$7.1M$23000
Résultat Net-$7.5M-$67.3M-$736.3M-$1.32B-$1.74B-$310.0M-$3.28B-$657.3M-$598.1M-$262.9M
BPA$-0.14$-0.31$-1.99$-3.96$-4.45$-7.70$-70.70$-8.79$-5.53$-0.88
BPA Dilué$-0.14$-0.31$-1.99$-3.90$-4.45$-7.70$-70.70$-8.79$-5.53$-0.88
Actions en Circulation (Diluées)$119.0M$177.3M$337.5M$356.1M$375.7M$39.1M$46.4M$74.8M$107.6M$2.98B

Compte de Résultat (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Revenus$66.7M$102.3M$71.2M$81.2M
Marge Brute$21.9M$29.5M$8.3M$22.2M
Résultat Opérationnel-$16.9M-$36.2M-$27.5M-$22.1M
EBITDA$16.6M-$63.1M-$137.0M-$4.7M
Résultat Net-$1.6M-$85.9M-$157.1M-$14.6M
BPA$-0.01$-0.25$-0.40$-0.03
BPA Dilué$-0.01$-0.25$-0.40$-0.03

Bilan (10 ans)

Année2017201820192020202120222023202420252026
Trésorerie$101.8M$322.6M$2.48B$915.6M$1.15B$776.0M$667.7M$170.3M$113.8M$364.7M
Placements à Court Terme00$2.06B$488.2M$1.16B$595.7M$105.5M$33.2M$17.7M$5.1M
Créances$5.8M$21.4M$107.0M$63.3M$67.1M$86.6M$68.5M$51.8M$52.8M$36.3M
Stocks$60.7M$118.0M$190.1M$274.8M$369.5M$204.5M$83.2M$77.3M$96.4M$154.1M
Actifs Courants$178.8M$481.8M$4.92B$1.80B$2.84B$1.73B$1.08B$371.2M$294.6M$529.5M
Immobilisations Corporelles$96.3M$303.7M$1.10B$1.07B$1.07B$942.8M$471.3M$320.1M$293.5M$441.4M
Goodwill$241.4M$314.9M$1.54B$1.37B$1.89B$1.87B$85.6M$43.2M$46.0M$77.7M
Actifs Incorporels$162.3M$101.5M$519.6M$334.7M$308.2M$252.7M$160.8M$104.1M$87.2M$128.9M
Actifs Totaux$677.6M$1.44B$8.73B$4.82B$6.82B$5.61B$2.44B$1.30B$917.7M$1.12B
Dettes Fournisseurs$5.7M$46.2M$188.9M$86.7M$67.3M$64.3M$31.8M$28.7M$26.1M$34.8M
Dette à Court Terme$1.7M$1.6M$103.7M$39.9M$9.8M$9.3M$556.9M$103.9M$4.3M$16.2M
Passifs Courants$17.7M$92.0M$411.7M$295.5M$284.3M$213.2M$803.8M$234.7M$94.4M$158.4M
Dette à Long Terme$8.6M$6.9M$842.3M$315.5M$1.57B$1.49B$750.0M$493.3M$299.8M$217.1M
Passifs Totaux$62.9M$193.6M$1.49B$1.18B$3.20B$1.98B$1.68B$799.8M$430.5M$421.1M
Réserves-$21.3M-$91.6M-$835.1M-$3.04B-$6.07B-$6.38B-$9.67B-$10.33B-$10.93B-$11.14B
Capitaux Propres$639.8M$1.16B$6.78B$3.43B$3.48B$3.58B$758.4M$500.4M$487.2M$697.6M
Dette Totale$10.3M$8.4M$946.0M$439.7M$1.72B$1.64B$1.41B$668.0M$348.4M$278.7M
Dette Nette-$91.5M-$314.1M-$3.60B-$964.1M-$598.3M$268.5M$640.5M$464.5M$216.9M-$92.0M
Fonds de Roulement$161.1M$389.7M$4.51B$1.51B$2.55B$1.51B$273.4M$136.5M$200.2M$371.0M

Bilan (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Trésorerie$298.1M$509.5M$364.7M$336.6M
Actifs Totaux$1.07B$1.52B$1.12B$1.10B
Passifs Totaux$333.8M$477.5M$421.1M$415.3M
Capitaux Propres$736.0M$1.04B$697.6M$688.6M
Dette Totale$259.3M$350.1M$278.7M$277.3M

Tableau de Flux (10 ans)

Année2017201820192020202120222023202420252026
Résultat Net-$7.6M-$54.1M-$736.3M-$1.39B-$1.67B-$258.9M-$3.08B-$483.7M-$604.1M-$262.9M
Amortissements$6.1M$20.5M$46.9M$125.0M$127.1M$110.9M$80.0M$53.2M$43.1M$36.5M
Stock-based Compensation$10.0M$51.2M$278.2M$320.3M$91.1M$46.7M$25.3M$14.2M-$4.2M$4.3M
Variation du BFR-$16.3M-$28.5M-$300.1M-$51.1M$27.7M$205.0M$59.0M$4.0M-$32.0M$20.7M
Cash Flow Opérationnel-$27.1M-$81.5M-$535.0M-$772.6M-$465.7M-$545.8M-$557.5M-$281.9M-$165.8M-$63.8M
CapEx-$29.5M-$178.1M-$718.8M-$721.9M-$174.1M-$48.1M-$10.5M-$4.0M-$11.3M-$6.0M
Acquisitions$11.2M-$29.9M-$388.0M-$504.0M$7.0M$103.2M$14.9M-$955000-$7.0M-$41.5M
Rachat d'Actions0000000000
Dividendes Payés0000000000
Free Cash Flow-$56.6M-$259.6M-$1.25B-$1.49B-$639.9M-$593.9M-$568.0M-$285.9M-$177.0M-$69.8M

Tableau de Flux (Trimestriel)

Année2025-Q32025-Q42026-Q12026-Q2
Cash Flow Opérationnel-$18.0M-$17.2M-$18.3M-$25.0M
CapEx-$1.5M-$1.9M-$1.1M-$737000
Free Cash Flow-$19.4M-$19.1M-$19.4M-$25.7M
Dividendes Payés0000
Stock-based Compensation$2.0M$888000$1.5M$1.4M

Croissance et Marges (10 ans)

Année2017201820192020202120222023202420252026
Croissance Revenus (annuelle)+95.4%+190.4%+76.2%+37.1%-13.0%-29.9%-10.8%-9.5%+5.8%
Croissance Résultat Net (annuelle)-794.6%-994.3%-79.5%-32.1%+82.2%-957.3%+80.0%+9.0%+56.0%
Croissance BPA (annuelle)-121.4%-541.9%-99.0%-12.4%-73.0%-818.2%+87.6%+37.1%+84.1%
Variation Actions (annuelle)+49.0%+90.4%+5.5%+5.5%-89.6%+18.5%+61.3%+43.8%+2671.1%
Croissance FCF (annuelle)-358.5%-383.0%-19.2%+57.2%+7.2%+4.4%+49.7%+38.1%+60.6%
Marge Brute97.0%95.2%39.3%-7.9%12.2%-39.4%-19.1%27.2%29.6%24.5%
Marge Opérationnelle-35.3%-138.3%-271.8%-418.5%-227.5%-214.2%-789.3%-77.0%-43.5%-25.7%
Marge EBITDA-1.6%-122.8%-250.6%-345.4%-82.3%-11.1%-864.2%-105.3%-178.2%-66.1%
Marge Nette-18.9%-86.3%-325.3%-331.3%-319.2%-65.2%-983.7%-221.2%-222.4%-92.4%
Marge FCF-141.9%-333.0%-554.0%-374.8%-117.1%-124.9%-170.4%-96.2%-65.8%-24.5%
Taux d'Imposition Effectif-26.3%0.8%-0.6%8.1%0.8%3.3%0.2%-2.6%-1.2%-0.0%

Données par Action (10 ans)

Année2017201820192020202120222023202420252026
FCF par Action$-0.48$-1.46$-3.71$-4.20$-1.70$-15.18$-12.25$-3.82$-1.65$-0.02
Dividende par Action$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Actions en Circulation (Basiques)$119.0M$177.3M$337.5M$350.0M$375.3M$39.1M$46.4M$74.8M$107.6M$2.98B

Quoi regarder en Santé / Pharma

Le pipeline R&D est l'actif invisible. Brevets qui expirent = revenus qui s'évaporent. Regardez innovation et cash flow.

Rentabilité

Rentabilité des capitaux propres-29.85%
Rentabilité du capital investi-15.31%
Rentabilité des actifs-21.43%
Marge brute22.87%
Marge opérationnelle-46.89%
Marge nette-73.95%

Santé financière

Dette / Capitaux propres0.40
Ratio de liquidité3.04

Ratios Clés (10 ans)

Année2017201820192020202120222023202420252026
PER-761.01-1086.67-284.91-51.19-90.42-12.31-0.33-1.16-0.24-1.50
P/B19.8251.5428.2220.6743.371.031.451.520.295.64
P/V317.77766.24845.46177.94276.227.803.292.560.5213.83
Marge Brute97.0%95.2%39.3%-7.9%12.2%-39.4%-19.1%27.2%29.6%24.5%
Marge Opérationnelle-35.3%-138.3%-271.8%-418.5%-227.5%-214.2%-789.3%-77.0%-43.5%-25.7%
Marge Nette-18.9%-86.3%-325.3%-331.3%-319.2%-65.2%-983.7%-221.2%-222.4%-92.4%

Entreprises liées: ACB · ACRS · BIOA · CABA · DH · IRWD · LFCR

Explorer le secteur: Healthcare · Drug Manufacturers - Specialty & Generic

Plus de sections de CGC: Vue d'ensemble · Valorisation · Statistiques · Estimations · Technique · Actionnariat · Actualités · Événements

Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions